Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akebia Therapeutics Inc. buy Piper Sandler

Akebia Therapeutics Inc.
Start price
€1.15
06.02.26 / 50%
Target price
€3.39
06.02.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 06.02.27. The prediction end date can be changed by Piper_Sandler at any time.
Performance without dividends (%)
Name 1w
Akebia Therapeutics Inc. -
iShares Core DAX® 1.085%
iShares Nasdaq 100 -1.665%
iShares Nikkei 225® 3.863%
iShares S&P 500 0.111%

Comments by Piper_Sandler for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 3.393
Change
Ends at 06.02.27

Akebia Therapeutics (NASDAQ:AKBA) had its price target lowered by analysts at Piper Sandler from $6.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for AKBA provided by MarketBeat

Piper Sandler 
0
Report Share
06.02.26

Stopped prediction by Piper_Sandler for Akebia Therapeutics Inc.

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.97
14.03.25
€5.53
14.03.26
-40.40%
06.02.26

Piper Sandler 
14.03.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
31.05.23
-
31.05.24
13.76%
01.06.24

Piper Sandler 
31.05.23 50%